Allergan reveals plans to buy US med tech Zeltiq for $2.5bn
Allergan’s spending spree is continuing with a deal worth nearly $2.5 billion for California, USA-based med tech group Zeltiq, in a move designed to further boost its aesthetics portfolio.
Read More
